Joseph Montecalvo

3.1k total citations · 2 hit papers
28 papers, 1.2k citations indexed

About

Joseph Montecalvo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Joseph Montecalvo has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 5 papers in Surgery. Recurrent topics in Joseph Montecalvo's work include Lung Cancer Diagnosis and Treatment (8 papers), Radiomics and Machine Learning in Medical Imaging (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Joseph Montecalvo is often cited by papers focused on Lung Cancer Diagnosis and Treatment (8 papers), Radiomics and Machine Learning in Medical Imaging (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Joseph Montecalvo collaborates with scholars based in United States, Japan and Canada. Joseph Montecalvo's co-authors include Natasha Rekhtman, William D. Travis, Charles M. Rudin, Jason C. Chang, Marc Ladanyi, Prasad S. Adusumilli, Maria E. Arcila, Ai Ni, Mark G. Kris and Gregory J. Riely and has published in prestigious journals such as Journal of Clinical Oncology, The Lancet Oncology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Joseph Montecalvo

26 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial

2016 327 citations Alexander Drilon, Natasha Rekhtman et al. The Lancet Oncology profile →
SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization

2020 301 citations Marina K. Baine, Min‐Shu Hsieh et al. Journal of Thoracic Oncology profile →

Peers

Joseph Montecalvo

PRM

ONCOL

EPIDE

Siobhan Nicholson Ireland

Erik Thunnissen Netherlands

Sandrine Hiret France

Monika Serke Germany

Vinicius Ernani United States

Marco Bartolotti Italy

Cecilia Bozzetti Italy

Thaddeus Beck United States

Madeline Vazquez United States

Christian Casali Italy

Siobhan Nicholson Ireland

Joseph Montecalvo

344 ×0.5

PRM

547 ×0.8

ONCOL

262 ×0.8

EPIDE

219 ×0.7

100 ×0.6

Citations per year, relative to Joseph Montecalvo Joseph Montecalvo (= 1×) peers Siobhan Nicholson

Countries citing papers authored by Joseph Montecalvo

Since Specialization

Citations

This map shows the geographic impact of Joseph Montecalvo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Montecalvo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Montecalvo more than expected).

Fields of papers citing papers by Joseph Montecalvo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Montecalvo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Montecalvo. The network helps show where Joseph Montecalvo may publish in the future.

Co-authorship network of co-authors of Joseph Montecalvo

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Montecalvo. A scholar is included among the top collaborators of Joseph Montecalvo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Montecalvo. Joseph Montecalvo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Montecalvo, Joseph, et al.. (2024). Benign Metastasizing Leiomyoma in a Patient With No Known History of Uterine Leiomyomas. Cureus. 16(8). e68314–e68314. 1 indexed citations

Montecalvo, Joseph, et al.. (2023). Acute Fibrinous and Organizing Pneumonia Due to Sirolimus Induced Lung Toxicity in a Bilateral Lung Transplant Patient. A6661–A6661.

Kezlarian, Brie, Joseph Montecalvo, Francis M. Bodd, et al.. (2023). Diagnosis of thoracic SMARCA4‐deficient undifferentiated tumor in cytology. Cancer Cytopathology. 131(8). 526–534. 7 indexed citations

Perry, Kyle, Joseph Montecalvo, & Anamarija M. Perry. (2021). Sarcomas of the mediastinum with epithelioid morphology. Mediastinum. 5. 4–4. 1 indexed citations

Schoenfeld, Adam J., Joseph Montecalvo, Azadeh Namakydoust, et al.. (2020). A07 The Genomic Landscape of SMARCA4 Alterations and Association with Patient Outcomes in Lung Cancer. Journal of Thoracic Oncology. 15(2). S14–S14. 1 indexed citations

Halpenny, Darragh, Etay Ziv, Andrew J. Plodkowski, et al.. (2020). Percutaneous computed tomography guided biopsy of sub-solid pulmonary nodules: differentiating solid from ground glass components at the time of biopsy. Clinical Imaging. 69. 332–338. 4 indexed citations

Baine, Marina K., Min‐Shu Hsieh, W. Victoria Lai, et al.. (2020). SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization. Journal of Thoracic Oncology. 15(12). 1823–1835. 301 indexed citations breakdown →

Rekhtman, Natasha, Patrice Desmeules, M. Catherine Pietanza, et al.. (2019). Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices. Modern Pathology. 32(8). 1106–1122. 55 indexed citations

Offin, Michael, Sebastián Mondaca, Joseph Montecalvo, et al.. (2019). P1.04-39 Molecular Characteristics, Immunophenotype, and Immune Checkpoint Inhibitor Response in BRAF Non-V600 Mutant Lung Cancers. Journal of Thoracic Oncology. 14(10). S455–S455. 11 indexed citations

10.

Eguchi, Takashi, Koji Kameda, Shaohua Lu, et al.. (2018). Lobectomy Is Associated with Better Outcomes than Sublobar Resection in Spread through Air Spaces (STAS)-Positive T1 Lung Adenocarcinoma: A Propensity Score–Matched Analysis. Journal of Thoracic Oncology. 14(1). 87–98. 172 indexed citations

11.

Yagi, Yukako, Rania G. Aly, Kazuhiro Tabata, et al.. (2018). OA03.07 Three-Dimensional Immunofluorescence Analysis of Dynamic Vessel Co-Option of Spread Through Air Spaces (STAS) in Lung Cancer. Journal of Thoracic Oncology. 13(10). S327–S327. 4 indexed citations

12.

Aherne, Emily A., Andrew J. Plodkowski, Joseph Montecalvo, et al.. (2018). What CT characteristics of lepidic predominant pattern lung adenocarcinomas correlate with invasiveness on pathology?. Lung Cancer. 118. 83–89. 23 indexed citations

13.

Brandt, Whitney S., Wanpu Yan, Jian Zhou, et al.. (2018). Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non–small cell lung cancer: A propensity-matched analysis. Journal of Thoracic and Cardiovascular Surgery. 157(2). 743–753.e3. 26 indexed citations

14.

Sabari, Joshua K., Michael Offin, Ai Ni, et al.. (2018). RET-rearranged lung cancers: Immunophenotype and response to immunotherapy.. Journal of Clinical Oncology. 36(15_suppl). 9034–9034. 9 indexed citations

15.

Tan, Kay See, Neel P. Chudgar, Whitney S. Brandt, et al.. (2017). BRMS1 Expression in Surgically Resected Lung Adenocarcinoma Predicts Future Metastases and Is Associated with a Poor Prognosis. Journal of Thoracic Oncology. 13(1). 73–84. 17 indexed citations

16.

Rekhtman, Natasha, Joshua K. Sabari, Joseph Montecalvo, et al.. (2017). Pulmonary large cell neuroendocrine carcinoma with adenocarcinoma-like features: napsin A expression and genomic alterations. Modern Pathology. 31(1). 111–121. 47 indexed citations

17.

Kameda, Koji, Shaohua Lu, Takashi Eguchi, et al.. (2017). MA12.05 Can Tumor Spread through Air Spaces (STAS) in Lung Adenocarcinomas Be Predicted Pre- and Intraoperatively?. Journal of Thoracic Oncology. 12(1). S411–S412. 10 indexed citations

18.

Drilon, Alexander, Natasha Rekhtman, Maria E. Arcila, et al.. (2016). Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: an open-label, single-centre, phase 2, single-arm trial. The Lancet Oncology. 17(12). 1653–1660. 327 indexed citations breakdown →

19.

Leeman, Jonathan E., Andreas Rimner, Joseph Montecalvo, et al.. (2016). Histologic Subtype of Early-Stage Lung Adenocarcinoma Predicts Failure Patterns in Patients Treated With Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 96(2). S11–S11. 1 indexed citations

20.

Leeman, Jonathan E., Andreas Rimner, Joseph Montecalvo, et al.. (2016). Histologic Subtype in Core Lung Biopsies of Early-Stage Lung Adenocarcinoma is a Prognostic Factor for Treatment Response and Failure Patterns After Stereotactic Body Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 97(1). 138–145. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact